USP39 Phase Separates into the Nucleolus and Drives Lung Adenocarcinoma Progression by Promoting GLI1 Expression

Overview

Journal Cell Commun Signal

Publisher Biomed Central

Date 2025 Jan 30

PMID 39885503

Authors

Shaoxuan Cheng

Zhiyuan Qiu

Ziyi Zhang

Yuxuan Li

Yue Zhu

Yuxin Zhou

Yinghui Yang

Yaowen Zhang

Dian Yang

Yingqiu Zhang

Han Liu

Zhaoxia Dai

Shu-Lan Sun

Shuyan Liu

Affiliations

Soon will be listed here.

Abstract

Background: Intracellular membraneless organelles formed by liquid-liquid phase separation (LLPS) function in diverse physiological processes and have been linked to tumor-promoting properties. The nucleolus is one of the largest membraneless organelle formed through LLPS. Deubiquitylating enzymes (DUBs) emerge as novel therapeutic targets against human cancers. However, the nucleolar phase separation of DUBs and association with lung cancer development have remained incompletely investigated till now.

Methods: GFP-USP39 fusion proteins were analyzed for LLPS properties using immunofluorescence, fluorescence recovery after photobleaching (FRAP) and in vitro LLPS assays. Intrinsically-disordered regions of USP39 were analyzed by PhaSepDB database. Transcriptomic profiling, Western blot, RT-PCR and luciferase reporter assays were conducted to identify targets regulated by USP39. The effects of USP39 depletion on tumor progression were tested using doxycycline-inducible USP39 knockdown and rescue lung adenocarcinoma cells both in vitro and in vivo by performing MTT, colony formation, EdU staining, transwell and tumor xenograft model experiments.

Results: USP39 phase separates into nucleoli depending upon its N-terminal disordered region with amino acid residues 1-103. Lung cancer cell growth and migration were dramatically inhibited by USP39 knockdown, which was rescued by exogenous USP39 complementation. Moreover, knockdown of USP39 reduced oncogenic transcription effector GLI1 levels. Finally, USP39 downregulation restricted the formation of lung cancer xenografts in nude mice.

Conclusions: USP39 undergoes LLPS in the nucleolus and promotes tumor progression by regulating GLI1 expression. Downregulation of USP39 effectively suppressed lung cancer growth, and therefore targeting USP39 provides novel therapeutic strategy to treat lung cancer.

References

Zheng J, Wu S, Tang M, Xi S, Wang Y, Ren J . USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC. Cell Death Dis. 2023; 14(10):670. PMC: 10567755. DOI: 10.1038/s41419-023-06210-3. View

Chang G, Xie G, Ma L, Li P, Li L, Richard H . USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5. Neuro Oncol. 2022; 25(5):841-853. PMC: 10158114. DOI: 10.1093/neuonc/noac238. View

Ding R, Yu X, Hu Z, Dong Y, Huang H, Zhang Y . Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells. Immunity. 2024; 57(3):528-540.e6. DOI: 10.1016/j.immuni.2024.01.019. View

Soragni A, Janzen D, Johnson L, Lindgren A, Nguyen A, Tiourin E . A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas. Cancer Cell. 2016; 29(1):90-103. PMC: 4733364. DOI: 10.1016/j.ccell.2015.12.002. View

Mehta S, Zhang J . Liquid-liquid phase separation drives cellular function and dysfunction in cancer. Nat Rev Cancer. 2022; 22(4):239-252. PMC: 10036213. DOI: 10.1038/s41568-022-00444-7. View

Carotenuto P, Pecoraro A, Palma G, Russo G, Russo A . Therapeutic Approaches Targeting Nucleolus in Cancer. Cells. 2019; 8(9). PMC: 6770360. DOI: 10.3390/cells8091090. View

Zou H, Pan T, Gao Y, Chen R, Li S, Guo J . Pan-cancer assessment of mutational landscape in intrinsically disordered hotspots reveals potential driver genes. Nucleic Acids Res. 2022; 50(9):e49. PMC: 9122534. DOI: 10.1093/nar/gkac028. View

Zhang W, Luo J, Xiao Z, Zang Y, Li X, Zhou Y . USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP. Cell Death Dis. 2022; 13(12):1021. PMC: 9722938. DOI: 10.1038/s41419-022-05474-5. View

Lafontaine D, Riback J, Bascetin R, Brangwynne C . The nucleolus as a multiphase liquid condensate. Nat Rev Mol Cell Biol. 2020; 22(3):165-182. DOI: 10.1038/s41580-020-0272-6. View

10.

Li W, Guo Z, Zhou Z, Zhou Z, He H, Sun J . Distinguishing high-metastasis-potential circulating tumor cells through fluidic shear stress in a bloodstream-like microfluidic circulatory system. Oncogene. 2024; 43(30):2295-2306. DOI: 10.1038/s41388-024-03075-4. View

11.

Jiang T, Zhu J, Jiang S, Chen Z, Xu P, Gong R . Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy. Adv Sci (Weinh). 2023; 10(17):e2207257. PMC: 10265098. DOI: 10.1002/advs.202207257. View

12.

Dong X, Liu Z, Zhang E, Zhang P, Wang Y, Hang J . USP39 promotes tumorigenesis by stabilizing and deubiquitinating SP1 protein in hepatocellular carcinoma. Cell Signal. 2021; 85:110068. DOI: 10.1016/j.cellsig.2021.110068. View

13.

Boyko S, Surewicz W . Tau liquid-liquid phase separation in neurodegenerative diseases. Trends Cell Biol. 2022; 32(7):611-623. PMC: 9189016. DOI: 10.1016/j.tcb.2022.01.011. View

14.

Song D, Kuang L, Yang L, Wang L, Li H, Li X . Yin and yang regulation of stress granules by Caprin-1. Proc Natl Acad Sci U S A. 2022; 119(44):e2207975119. PMC: 9636964. DOI: 10.1073/pnas.2207975119. View

15.

Liu Z, Qin Z, Liu Y, Xia X, He L, Chen N . Liquid‒liquid phase separation: roles and implications in future cancer treatment. Int J Biol Sci. 2023; 19(13):4139-4156. PMC: 10496506. DOI: 10.7150/ijbs.81521. View

16.

Zhang J, Liu S, Li Q, Shi Y, Wu Y, Liu F . The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer. Cell Death Differ. 2020; 27(9):2710-2725. PMC: 7429833. DOI: 10.1038/s41418-020-0538-8. View

17.

Banani S, Lee H, Hyman A, Rosen M . Biomolecular condensates: organizers of cellular biochemistry. Nat Rev Mol Cell Biol. 2017; 18(5):285-298. PMC: 7434221. DOI: 10.1038/nrm.2017.7. View

18.

Cui D, Wang Z, Dang Q, Wang J, Qin J, Song J . Spliceosome component Usp39 contributes to hepatic lipid homeostasis through the regulation of autophagy. Nat Commun. 2023; 14(1):7032. PMC: 10624899. DOI: 10.1038/s41467-023-42461-6. View

19.

Sowa M, Bennett E, Gygi S, Harper J . Defining the human deubiquitinating enzyme interaction landscape. Cell. 2009; 138(2):389-403. PMC: 2716422. DOI: 10.1016/j.cell.2009.04.042. View

20.

Wang C, Lu H, Liu X, Gao X, Tian W, Chen H . A natural product targets BRD4 to inhibit phase separation and gene transcription. iScience. 2022; 25(1):103719. PMC: 8762392. DOI: 10.1016/j.isci.2021.103719. View